GlobeNewswire by notified

RIB Software launches free-to-use RIB Carbon Quantifier for optimized carbon quantification in construction

Share

RIB Software launches free-to-use RIB Carbon Quantifier for optimized carbon quantification in construction.RIB Software, a leading multinational provider of innovative technology solutions to the architecture, engineering, and construction (AEC) industries, has partnered with non-profit organization, Building Transparency, to develop the RIB Carbon Quantifier. Through a direct link with Building Transparency’s Embodied Carbon in Construction Calculator (EC3), the application allows users to quickly, easily and consistently allocate carbon environmental product declaration (EPD) values against their imported estimate data, including resource quantities.

RIB Software launches free-to-use RIB Carbon Quantifier for optimized carbon quantification in construction.

RIB Software, a leading multinational provider of innovative technology solutions to the architecture, engineering, and construction (AEC) industries, has partnered with non-profit organization, Building Transparency, to develop the RIB Carbon Quantifier. 

Through a direct link with Building Transparency’s Embodied Carbon in Construction Calculator (EC3), the application allows users to quickly, easily and consistently allocate carbon environmental product declaration (EPD) values against their imported estimate data, including resource quantities. 

This comes as studies highlight the industry’s impact on the environment, with construction constituting a staggering 39% of global greenhouse gas emissions and accounting for 36% of global energy demands.

René Wolf, Chief Executive Officer at RIB Software, says there is a growing need to reduce carbon emissions within the engineering and construction sector to combat the damaging effects of climate change. 

“Until recently, the construction industry’s response to reducing building-related emissions has focused on energy efficiency by reducing operational emissions - the energy used to heat, cool and light buildings. 

“While previously effective, this approach overlooks embodied carbon emissions associated with material and construction processes across a building’s lifecycle, which represents a quarter of the carbon emitted during the life of a building and 11% of all global carbon emissions. 

“It is therefore critical to increase efforts to quantify, monitor, evaluate and ultimately reduce the embodied carbon emitted throughout the lifecycle of a construction project - and the driving factor for why RIB Software developed the Carbon Quantifier application,” explains Wolf.

Through a seamless integration with Building Transparency’s premier, free-to-use EC3 tool, the RIB Carbon Quantifier application is set to be the first of its kind in the industry to assist the built environment in extracting and quantifying embodied carbon data more quickly and efficiently, optimizing carbon quantification and reducing estimate delivery times. 

Through this powerful partnership of technology, industry professionals will now have access to an additional toolset to optimize the efficiency in the quantification and measurement of carbon, thus better facilitating design and procurement decisions, helping the global AEC industry in achieving a lower embodied carbon footprint. 

Stacy Smedley, Executive Director of Building Transparency, says reducing embodied carbon emissions is one of the biggest opportunities in the fight against global warming. “Partnerships, like ours with RIB Software, are critical to driving action in the building sector and identifying new solutions that make it easier to prioritize low-carbon decision-making on projects. It’s exciting to have our EC3 data and its large carbon impact database be utilized and leveraged for tools like the RIB Carbon Quantifier.” 

The primary features of the RIB Carbon Quantifier include the easy extraction of embodied carbon data from Building Transparency’s EC3 database against estimates; keeping a repository of each estimate’s embodied carbon data for cross-referencing and facilitating easier allocation of carbon values for future projects; the ability to easily export aligned quantified data back to EC3 for analytics, reporting and dashboarding; and providing users with a direct integration with other estimating products within the RIB portfolio of products.

Wolf says the need to accelerate decarbonization practices in the AEC industry is critical, and using an application like the RIB Carbon Quantifier will not only allow users to optimize carbon quantification, but will ensure they avoid unnecessary energy spent and emissions generated from associated projects and processes.

“At RIB, we are driven by transformative digital technologies, industry best-practice and trends that help propel the industry forward and make engineering and construction more efficient and sustainable,” he concludes.

For more information about the RIB Carbon Quantifier, email cq@rib-software.com or visit rib-software.com/en/home/carbon-quantifier

[ENDS]

Press Enquiries

Kim Immelman
kim.immelman@rib-software.com

Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Novartis radioligand therapy Lutathera® FDA approved as first medicine specifically for pediatric patients with gastroenteropancreatic neuroendocrine tumors23.4.2024 19:42:34 CEST | Press release

Approval based on NETTER-P trial in which Lutathera demonstrated a consistent safety profile and comparable drug exposure between pediatric (ages 12-17) and adult patients Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are a rare cancer that is often unresectable and commonly diagnosed in the late stages of disease Novartis, a leader in radioligand therapy (RLT), is investigating a portfolio of RLTs to treat a broad range of cancers, including GEP-NETs, lung, prostate, breast, colon, brain and pancreatic cancers Basel, April 23, 2024 – Novartis today announced that the U.S. Food and Drug Administration (FDA) approved Lutathera® (USAN: lutetium Lu 177 dotatate / INN: lutetium (177Lu) oxodotreotide) for the treatment of pediatric patients 12 years and older with somatostatin receptor-positive (SSTR+) gastroenteropancreatic neuroendocrine tumors (GEP-NETs), including foregut, midgut, and hindgut NETs. This approval makes Lutathera the first therapy specifically reviewed and appro

Grant of warrants23.4.2024 19:20:21 CEST | Press release

23 April 2024 Announcement no. 9 Grant of Warrants COPENHAGEN, DENMARK and BOSTON, MA, USA, April 23, 2024 (GLOBE NEWSWIRE) – The Board of Directors of BioPorto A/S (“BioPorto” or the “Company”) (CPH:BIOPOR) has resolved, in accordance with the annual general meeting’s resolution on April 27, 2023, to issue a total of 4,000,000 warrants to members of the Executive Management. Each warrant grants the holder the right to subscribe for one share in BioPorto. The exercise price is DKK 1.23 per share, corresponding to the closing price today on Nasdaq Copenhagen. The warrants are issued in accordance with section 18 a of the Articles of Association. Half of the warrants vest over a 2-year period, and the remaining half upon completion of a qualified capital raise in the Company with terms of qualification (including timing and amount of proceeds) to be defined by the Board of Directors. The warrants are otherwise subject to the Company’s incentive warrant program as included in Appendix 1 o

TrueCommerce leverer globale e-fakturerings- og CTC-løsninger til virksomheder, der har udfordringer med overholdelse23.4.2024 19:10:28 CEST | pressemeddelelse

Virksomheden er ene om at tilbyde en global løsning, der omfatter e-fakturering, CTC-løsninger og et omfattende EDI-netværk, alt sammen problemfritintegreret med B2B e-handels- og ERP-systemer KØBENHAVN, Danmark, April 23, 2024 (GLOBE NEWSWIRE) -- TrueCommerce, en global leverandør af forsyningskæde- og handelspartnerforbindelser, integration og løsninger via flere kanaler, har i dag givet meddelelse om sin globale løsning til e-fakturering og Continuous Transaction Controls (CTC), der gør det muligt for organisationer at holde trit med de konstant skiftende juridiske krav overalt i verden og understøtter elektronisk fakturering, som opfylder de gældende krav. TrueCommerce er en global markedsaktør, der understøtter både e-fakturering og CTC og giver adgang til et omfattende globalt EDI-netværk samt B2B e-handel og ERP-integration. På grund af kompleksiteten i at navigere i et landskab af stadigt skiftende landespecifikke e-faktureringskrav og deadlines, står virksomheder over for en s

Festi hf.: Financial results for Q1 202423.4.2024 19:02:17 CEST | Press release

Key findings Sale of goods amounted to ISK 32,223 million, compared to ISK 29,484 million in the previous year, an increase of 9.3% between years.Gross profit from sales of goods and services amounted to ISK 7,033 million, an increase of 806 million or 12.9% between years.Profit Margins from sales of goods and services were 21.8% and increases by 0.7 p.p. from Q1 2023 but decreases by 1.2 p.p. from Q4 2023.Salaries and other personnel expenses increase by 7.5% and full-time equivalents by 2.5%.EBITDA amounted to ISK 1,898 million compared to ISK 1,401 million in Q1 2023, increase of 35.5% between years. Profit for the quarter amounted to ISK 202 million, or 2.9% of margin, a turnaround of ISK 293 million YoY.Net cash from operating activities was ISK 538 million or 7.6% of margin, compared to ISK 1,238 million last year.Equity at the end of Q1 2024 amounted to ISK 35,140 million with an equity ratio of 36.0%. EBITDA forecast for the year 2024 is raised by ISK 300 million and is now ISK

ASM reports first quarter 202423.4.2024 18:00:00 CEST | Press release

Almere, The Netherlands April 23, 2024, 6 p.m. CET Solid start of the year, Q1 orders supported by GAA and HBM ASM International N.V. (Euronext Amsterdam: ASM) today reports its Q1 2024 results (unaudited). Financial highlights € millionQ1 2023Q4 2023Q1 2024 New orders 647.4 677.5 697.9 yoy change % at constant currencies (6%) (14%) 10% Revenue 710.0 632.9 639.0 yoy change % at constant currencies 40% (7%) (8%) Gross profit margin % 49.4 % 47.2 % 52.9 % Adjusted gross profit margin 1 51.1 % 47.9 % 52.9 % Operating result 204.2 131.5 187.1 Operating result margin % 28.8 % 20.8 % 29.3 % Adjusted operating result 1 221.2 141.0 191.8 Adjusted operating result margin 1 31.2 % 22.3 % 30.0 % Net earnings 380.4 90.9 173.1 Adjusted net earnings 1 183.0 100.3 178.9 1 Adjusted figures are non-IFRS performance measures (previously referred to as "normalized"). Refer to Annex 3 for a reconciliation of non-IFRS performance measures. New orders of €698 million in Q1 2024 increased by 10% at constant

HiddenA line styled icon from Orion Icon Library.Eye